Evolus, Inc.

NasdaqGM:EOLS Stock Report

Market Cap: US$701.6m

Evolus Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGM:EOLS Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
06 Sep 24SellUS$49,074Sandra BeaverIndividual3,276US$14.98
30 Aug 24SellUS$89,251Tomoko Yamagishi-DresslerIndividual5,631US$15.85
04 Jun 24SellUS$1,784,686David MoatazediIndividual140,214US$12.73
03 Jun 24SellUS$97,203Vikram MalikIndividual7,500US$12.96
14 May 24SellUS$131,010David GillIndividual10,361US$12.72
13 May 24SellUS$362,012Vikram MalikIndividual28,000US$12.93
10 May 24SellUS$30,814Sandra BeaverIndividual2,423US$12.72
10 May 24SellUS$43,761Rui AvelarIndividual3,441US$12.72
10 May 24SellUS$204,127David MoatazediIndividual16,051US$12.72
27 Mar 24SellUS$86,431David MoatazediIndividual6,236US$13.86
19 Mar 24SellUS$1,344,604David MoatazediIndividual96,566US$13.92
19 Mar 24SellUS$78,978Sandra BeaverIndividual5,672US$13.92
19 Mar 24SellUS$384,350Rui AvelarIndividual27,603US$13.92
22 Feb 24SellUS$100,804David MoatazediIndividual7,706US$13.08

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of EOLS?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders1,248,0321.97%
Public Companies3,136,8694.95%
Private Companies3,381,3265.34%
General Public4,967,4657.84%
VC/PE Firms5,356,6228.46%
Institutions45,231,17971.4%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 10.8%.

Top Shareholders

Top 25 shareholders own 73% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
8.46%
Perceptive Advisors LLC
5,356,622US$59.4m-6.9%1.4%
7.66%
Tang Capital Management, LLC
4,847,399US$53.7m0%4.0%
6.68%
BlackRock, Inc.
4,230,149US$46.9m5.54%no data
5.34%
Medytox Korea Co. Ltd
3,381,326US$37.5m0%no data
5.05%
The Vanguard Group, Inc.
3,195,331US$35.4m7.04%no data
4.95%
Daewoong Pharmaceutical Co., Ltd
3,136,869US$34.8m0%no data
4.46%
Nantahala Capital Management, LLC
2,824,849US$31.3m-2.95%2.34%
3.46%
Caligan Partners, LP
2,193,488US$24.3m1.19%7.67%
2.16%
Stonepine Capital Management LLC
1,369,821US$15.2m-17.4%5.49%
2.02%
State Street Global Advisors, Inc.
1,277,841US$14.2m-4.57%no data
1.91%
Geode Capital Management, LLC
1,210,621US$13.4m0.92%no data
1.85%
Great Point Partners, LLC
1,170,000US$13.0m-52.3%4.93%
1.64%
Soleus Capital Management, L.P.
1,037,680US$11.5m-9.92%0.9%
1.63%
Millennium Management LLC
1,029,670US$11.4m14.5%0.01%
1.6%
Schroder Investment Management North America Inc.
1,014,960US$11.2m3.82%0.04%
1.57%
Lord, Abbett & Co. LLC
995,449US$11.0m23.4%0.03%
1.55%
Boothbay Fund Management, LLC
983,702US$10.9m-1.29%0.36%
1.55%
Morgan Stanley, Investment Banking and Brokerage Investments
979,326US$10.9m-31.7%no data
1.53%
D. E. Shaw & Co., L.P.
970,270US$10.8m11.4%0.01%
1.51%
Assenagon Asset Management S.A.
955,555US$10.6m0.89%0.02%
1.43%
Rice Hall James & Associates, LLC
904,900US$10.0m6.3%0.53%
1.41%
Teachers Insurance and Annuity Association-College Retirement Equities Fund
894,742US$9.9m50.6%no data
1.34%
Soros Fund Management LLC
850,000US$9.4m0%0.25%
1.19%
UBS Asset Management AG
753,532US$8.3m-2.06%no data
1.04%
AWH Capital, L.P.
657,500US$7.3m-2.59%6.64%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/19 05:40
End of Day Share Price 2024/12/19 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Evolus, Inc. is covered by 13 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Balaji PrasadBarclays
Balaji PrasadBarclays
Navann Ty DietschiBNP Paribas Exane